Achieve Life Sciences Inc (ACHV NASDAQ) stock market data APIs
$2.9747
0.11(3.7%)
as of September 17, 2025
Try our APIs with
free plan!
Achieve Life Sciences Inc Financial Data Overview
Price chart is built with
Anychart
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Prev. Close
2.9747
Open
3.0876
High
3.0624
Low
2.9747
52 wk Range
1.84-5.31
Market Cap
157 M
Shares Outstanding
51 105 K
EPS
-0.37
Beta
1.539
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Achieve Life Sciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Achieve Life Sciences Inc data using free add-ons & libraries
Get Achieve Life Sciences Inc Fundamental Data
Achieve Life Sciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -49 881 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.37
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Achieve Life Sciences Inc News
New
Achieve Life Sciences gets new interim chief medical officer
* Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]) said that [https://seekingalpha.com/pr/20230175-achieve-life-sciences-names-dr-mark-rubinstein-interim-chief-medical-offi...
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global developmen...
Achieve Life Sciences' nicotine dependence treatment under FDA review
[Cigarette with prohibition sign on wooden table, top view. Quitting smoking concept] Liudmila Chernetska/iStock via Getty Images * Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symb...
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
SEATTLE and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global developmen...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
